BackGalera Therapeutics Overview

Galera Therapeutics Current Cash

Latest current cash for GRTX: $5.5M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$5.50M
↓ 17.74% YoYΔ $-1.19M vs prior year quarter

Peer average

Loading

Galera Therapeutics Current Cash History

Loading

Galera Therapeutics vs. peers: Current Cash Comparison

Loading

Galera Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Galera Therapeutics (GRTX) FAQ

Galera Therapeutics (GRTX) currently reports a current cash of $5.5M as of March 2026. That compares with $6.7M in the prior-year period — down 17.7% year over year. Use the charts on this page to explore Galera Therapeutics's current cash history and peer comparisons.

Galera Therapeutics's current cash decreased from $6.7M to $5.5M — a 17.7% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Galera Therapeutics reported $5.5M in current cash as of March 2026. That compares with $6.7M in the prior-year period — down 17.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $5.5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Galera Therapeutics, and consider following GRTX for alerts when major investors trade the stock.

Galera Therapeutics is classified in the Healthcare sector. On current cash, it currently shows $5.5M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GRTX with unrelated industries.